Implantable Medical Devices Market Analysis

  • Report ID: 6094
  • Published Date: May 30, 2024
  • Report Format: PDF, PPT

Implantable Medical Devices Market Analysis

Product (Cardiovascular, Ophthalmology, Orthopedic, Plastic Surgery, Dental, Neurology)

Cardiovascular segment is poised to account for more than 31% implantable medical devices market share by the end of 2036 driven by the increasing prevalence of several cardiovascular diseases in the population worldwide. According to a report by the World Health Organization in 2021, it was estimated that more than 17.9 million people died in 2019 attributed to cardiovascular diseases; this data registers a share of about 32% of global deaths.

Additionally, there is also an increase in technological advancements; increasing investments, coupled with the surge in the geriatric population, would help the cardiovascular segment dominate this implantable medical devices market expansion. The increase in such technological advancements has fueled the revenue share while improving the safety features, which makes them a better option for consumers.

Material (Stainless Steel, Titanium, Cobalt-Chromium Alloys, Titanium Alloys, Zirconium)

The stainless-steel segment is estimated to gain a robust implantable medical devices market share owing to the highly durable, resilient, and stable material, which makes it one of the most commonly, used materials for implantable medical devices. Stainless steel is a very resistant material, with a high strength and ability to withstand pressure, making it ideal for use in the human body.

According to a report, stainless steel 304 is regarded globally as the most suited material for the manufacturing of medical devices. Furthermore, stainless steel has a high resistance to corrosion and oxidization, which is a crucial factor in maintaining the long-term stability and reliability of implantable medical devices.

Nature of Device (Active, Passive)

The Active segment in the implantable medical devices market is estimated to exhibit around 9.2% CAGR till 2036. The reason behind this impact is projected by the increase in several devices such as defibrillators, ventricular assist systems, infusion pumps, pacemakers, and many more.

According to a report by the National Institutes of Health in 2021, from 2012 to 2018 there was an increase in public awareness regarding the knowledge of how to use Automated External Defibrillators (AED) grew from 4.7% to 20.8%.

Our in-depth analysis of the implantable medical devices market includes the following segments:

     Product

  • Cardiovascular
  • Implantable Cardiac Defibrillators [ICDs]
  • Stents
  • Pacemaker
  • Implantable Cardiac Monitors [ICM]
  • Ventricular Assist Devices
  • Cardiac Resynchronization Therapy Devices [CRT])
  • Ophthalmology
  • Intraocular Lenses
  • Glaucoma Implants
  • Orthopedic
  • Joint Reconstruction
  • Spinal Devices
  • Trauma Fixation Devices
  • Plastic Surgery
  • Breast Implants
  • Gluteal Implants
  • Dental
  • Dental Implants
  • Dental Crowns
  • Abutment
  • Neurology
  • Deep Brain Stimulators

     Type

  • Diagnostic
  • Treatment

     Nature of Device

  • Active
  • Passive

     Material

  • Stainless Steel
  • Titanium
  • Cobalt-Chromium Alloys
  • Titanium Alloys
  • Zirconium
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6094
  • Published Date: May 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of the implantable medical devices market was over USD 190 billion.

The market size for the implantable medical devices market is projected to cross USD 427 billion by the end of 2036 expanding at a CAGR of 7% during the forecast period i.e., between 2024-2036.

The major players in the market are Abbott, Boston Scientific Corporation, Zimmer Biomet Holdings, Stryker Corporation, Smith & Nephew plc, Becton, Dickinson, and Company, LivaNova, Edwards Lifesciences, Globus Medical, Inc., and others.

In terms of product, the cardiovascular segment is anticipated to account for the largest market share of 31% during 2024-2036.

The North American implantable medical devices sector is poised to hold the highest share of 43% by 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample